“TREATMENT OF TYPE 2 DIABETES MELLITUS WITH GLP-1 RECEPTOR AGONISTS, CHRONIC KIDNEY DISEASE AND INFLUENCE ON CARDIOVASCULAR RISK”. TRAKIA JOURNAL OF SCIENCES, vol. 23, no. Supplement 1, Oct. 2025, p. 6, https://doi.org/10.15547/tjs.2025.s.01.004.